ArticleBritish journal of clinical pharmacology2026
Effectiveness and safety of combining thiazides with loop diuretics vs. loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study.
Article in British journal of clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effectiveness and safety of combining thiazides with loop diuretics vs. loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study.British journal of clinical pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsThis study investigated factors associated with and outcomes of combined loop diuretics with hydrochlorothiazide (HCTZ) for acute decompensated heart failure (ADHF).
methodsIn this retrospective study, adults hospitalized for ADHF and who received intravenous loop diuretics between January 2016 and March 2023 were enrolled. Patients were categorized into two groups based on HCTZ use. Factors associated with combination therapy and clinical outcomes were examined. Effectiveness outcomes included weight change and percentage weight change, while safety outcomes focused on acute kidney injury (AKI) and worsening renal function at discharge.
resultsAmong 3493 enrolled patients, 329 received combination therapy. Factors associated with combination therapy included use of thiazide diuretics pre-admission (adjusted odds ratio [aOR]: 1.81; 95% confidence interval [CI]: 1.25-2.62), pre-admission dose of oral loop diuretics (aOR: 1.28 per defined daily dose; 95% CI: 1.05-1.56), lower estimated glomerular filtration rate (aOR: 0.98 per unit; 95% CI: 0.98-0.99), higher N-terminal pro-B-type natriuretic peptide levels (aOR: 1.02 per 1000 unit; 95% CI: 1.01-1.02), and lower serum albumin (aOR: 0.53 per unit; 95% CI: 0.41-0.68). Compared to loop diuretics monotherapy, weight reduction was greater in combination therapy (adjusted difference -1.2 kg; 95% CI: -1.5 to -0.9) and percentage of weight loss (adjusted difference -1.8%; 95% CI: -2.3 to -1.3), but higher risk of AKI (aOR: 2.7; 95% CI: 2.1-3.5) and worsening renal function at discharge (aOR: 2.4; 95% CI: 1.9-3.1).
conclusionsCombination therapy enhanced weight reduction in ADHF; however, it might increase the risk of renal dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.